CARTESIAN THERAPEUTICS INC (RNAC) Stock Balance Sheet
NASDAQ:RNAC • US8162123025
Current stock price
6.16 USD
-0.06 (-0.96%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 125.14M | 212.61M | 76.91M | 106.44M | 114.06M | |||
| Marketable Securities | N/A | N/A | 0.00 | 28.16M | 14.00M | |||
| Receivables | 1.11M | 872.00K | 8.85M | 9.76M | 9.91M | |||
| Other Current Assets | 3.02M | 3.14M | 4.97M | 3.78M | 6.47M | |||
| Total Current Assets | 129.28M | 216.63M | 90.73M | 148.14M | 144.44M | |||
| Non-Current Assets | ||||||||
| PPE Net | 17.79M | 15.45M | 12.18M | 14.41M | 11.97M | |||
| Investments And Advances | 0.00 | 2.00M | 2.00M | 2.00M | 2.00M | |||
| Goodwill | 48.16M | 48.16M | 48.16M | N/A | N/A | |||
| Intangibles | 93.90M | 150.60M | 150.60M | N/A | N/A | |||
| Other Non-Current Assets | 7.29M | 2.19M | 1.38M | 1.34M | 1.47M | |||
| Total Non-Current Assets | 167.13M | 218.40M | 214.32M | 17.75M | 15.44M | |||
| TOTAL ASSETS | 296.41M | 435.02M | 305.05M | 165.89M | 159.88M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 8.48M | 5.96M | |||
| Accrued Expenses | 13.65M | 14.93M | 17.74M | 15.69M | 11.58M | |||
| Accounts Payable | 1.29M | 288.00K | 3.15M | 316.00K | 224.00K | |||
| Other Current Liabilities | 0.00 | 7.76M | 47.32M | 593.00K | 54.48M | |||
| Total Current Liabilities | 14.94M | 22.98M | 68.21M | 25.08M | 72.25M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 17.79M | 19.67M | |||
| Deferred Taxes/Income | 6.95M | 16.14M | 15.85M | N/A | N/A | |||
| Other Non-Current Liabilities | 400.77M | 402.71M | 360.62M | 29.20M | 45.44M | |||
| Total Non-Current Liabilities | 407.71M | 418.85M | 376.47M | 46.98M | 65.11M | |||
| TOTAL LIABILITIES | 422.65M | 441.82M | 444.68M | 72.06M | 137.36M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -822.37M | -692.07M | -614.65M | -394.94M | -430.32M | |||
| Additional Paid In Capital | 700.71M | 689.89M | 179.05M | 493.31M | 457.39M | |||
| Common Shares | 3.00K | 3.00K | 300.57M | 15.00K | 12.00K | |||
| Other Shareholders' Equity | -4.58M | -4.62M | -4.60M | -4.56M | -4.57M | |||
| Shares Outstanding | 26.01M | 25.77M | 5.40M | 5.10M | 4.12M | |||
| Tangible Book Value per Share | -10.31 | -7.98 | -118.39 | 18.39 | 5.47 | |||
| Total Shareholders' Equity | -126.24M | -6.80M | -139.63M | 93.83M | 22.52M | |||
| TOTAL LIABILITIES AND EQUITY | 296.41M | 435.02M | 305.05M | 165.89M | 159.88M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.19 | 0.87 | |||
| Current Ratio | 8.65 | 9.43 | 1.33 | 5.91 | 2.00 | |||
| Return On Assets (ROA) | -43.96% | -17.80% | -72.02% | 21.33% | -16.07% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | 37.71% | -114.06% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 8.16% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 185.03% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | 185.03% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21